LuSeed Vascular
LuSeed Vascular
Minimally invasive device for treating brain aneurysms, compatible with robotic systems.
Rate
About
LuSeed Vascular has developed the DOME™ device, a first-in-class, minimally invasive solution for treating both bifurcation and sidewall brain aneurysms. Designed for simplicity and safety, the device is fully compatible with robotic systems, aiming to establish a standard method of care for neurosurgeons and interventional neuroradiologists.
Technology stack
detected 2026-06-15Email
Microsoft 365
Hosting
self_managed
Stack
jQuery
WordPress
Comments
No comments yet. Be the first to share your take.
Frequently asked
What does LuSeed Vascular do?
LuSeed Vascular has developed the DOME™ device, a first-in-class, minimally invasive solution for treating both bifurcation and sidewall brain aneurysms. Designed for simplicity and safety, the device is fully compatible with robotic systems, aiming to establish a standard method of care for neurosurgeons and interventional neuroradiologists.
Where is LuSeed Vascular headquartered?
LuSeed Vascular is headquartered in San Mateo, United States.
When was LuSeed Vascular founded?
LuSeed Vascular was founded in 2019.
What industry does LuSeed Vascular operate in?
LuSeed Vascular operates in Healthcare, Medical Device, MedTech, HealthTech, Surgical Robotics, Neurovascular.
How many employees does LuSeed Vascular have?
LuSeed Vascular has approximately 16 people on record.